Form 4: Tivic Health Systems Executive Granted 225,000 Restricted Stock Units

Blake Gurfein, Chief Scientific Officer of Tivic Health Systems, received 225,000 Restricted Stock Units (RSUs) on December 18, 2024, according to a recent SEC filing.

Summary

• Blake Gurfein, the Chief Scientific Officer of Tivic Health Systems, was granted 225,000 Restricted Stock Units (RSUs) on December 18, 2024.
• These RSUs are convertible into shares of Common Stock on a 1:1 basis.
• The vesting schedule dictates that 50% of the RSUs will vest one year after the Vesting Commencement Date.
• The remaining 50% will vest in eight equal quarterly installments over the subsequent two years, completing the vesting on the third anniversary of the Vesting Commencement Date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard executive compensation disclosure. The vesting schedule suggests a commitment from the executive.

Positives

• The grant of RSUs to a key executive like the Chief Scientific Officer can be seen as an incentive to align their interests with the long-term success of the company.

Future Outlook

The vesting schedule suggests a three-year commitment from the executive, aligning their interests with the company's performance over that period.

Industry Context

Granting stock-based compensation is a common practice in the biotech and healthcare industries to attract and retain key talent, aligning their interests with shareholder value.

Comparison to Industry Standards

• Stock option and RSU grants are a standard component of compensation packages for executives in publicly traded companies, particularly in growth-oriented sectors like healthcare.
• The vesting schedule of 3 years is a common vesting period for stock options and RSU's.
• Comparing the size of the grant (225,000 RSUs) to grants made by comparable companies to their Chief Scientific Officers would provide a benchmark for assessing the competitiveness of Tivic Health Systems' compensation practices.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive incentive for the Chief Scientific Officer to drive innovation and growth.
• Employees may see this as a sign of the company's commitment to its leadership team.

Key Dates

Keywords

Restricted Stock Units, RSUs, Tivic Health Systems, Executive Compensation, Beneficial Ownership, Form 4, Gurfein, Vesting